3.40
+4.29%
Close of 9 Nov 2026, in BRL
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Diagnosticos da America
Its shares trade on B3 under the ticker DASA3.SA. It has been listed since 19 November 2004. In the fiscal year to 31 December 2025, it reported revenue of BRL 11.17bn and a net loss of BRL 1.15bn. At that date it held total assets of BRL 18.56bn and shareholders' equity of BRL 6.87bn.
Diagnósticos da América SA engages in medical diagnostics services and in the business of research and development of diagnostic tests and their application to the medical practice. The company is headquartered in Barueri, Sao Paulo. The company went IPO on 2004-11-19. The Company’s services are structured into three units: Ambulatory and Hospital, which provides clinical analyses and diagnostic imaging; Laboratory support, which provides services for small and medium-sized laboratories, and Public Health Sector, in which the Company operates through the CientificaLab brand, which focuses on providing auxiliary diagnostic support services for the public health sector. In addition, the Company is engaged in activities related to tests in food and substances to evaluate risks for the human being; import, for its own use, of medical-hospital equipment, sets for diagnostics and related material in general, and granting and administration of business franchising, including advertising and publishing fund, training and selection of labor, supplying of equipment and research material suppliers, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 19 Nov 2004
- Website
- dasa3.com.br ↗
Leadership
Pay as last reported
- Dr. Dulce De Godoy BuenoChairman of the Board, since 2020
- Mr. Licio CintraChief Executive Officer
- Mr. Pedro De Godoy BuenoVice Chairman of the Board, since 2014
- Mr. Rafael BossolaniVice President of Finance and Investor Relations
- Ms. Anaterra ..Vice President of IT
- Mr. Helisson Brigido Andrade LemosVice President of Marketing and Products
- Mr. Andre CovreVice President of Corporate Strategy
- Mr. Roberto CuryVice President of Service Units and NAC
- Mr. Fabio Sampaio De LacerdaVice President of People, Management and Culture
- Mr. Leonardo VedolinVice President Medical and Production Director, since 2017
- Mr. Rafael LucchesiDirector of President
- Mr. Linaldo VilarProduction Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 79
- Environment
- 99
- Social
- 95
- Governance
- 44
- Direct emissions (scope 1)
- 28,570.05 t
- Energy emissions (scope 2)
- 4,468.53 t
- Value chain emissions (scope 3)
- 41,417.91 t
- Women in the workforce
- 77%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- One of the major strengths of Diagnosticos da America SA is its strong market presence and brand reputation in the diagnostic healthcare industry.
- The company has a wide range of diagnostic services and an extensive network of laboratories, which gives it a competitive edge over its rivals.
Weaknesses
- One of the weaknesses of Diagnosticos da America SA is its high dependence on the Brazilian market, which exposes it to risks associated with economic fluctuations and regulatory changes in the country.
- The company also faces challenges related to managing a large network of laboratories and maintaining consistent quality standards across all locations.
Opportunities
- There are several opportunities for Diagnosticos da America SA to expand its operations and diversify its market reach. The growing demand for diagnostic services, advancements in technology, and increasing focus on preventive healthcare provide a favorable environment for the company to capitalize on.
- The company can also explore international markets and strategic partnerships to further expand its business and tap into new customer segments.
Threats
- Diagnosticos da America SA faces threats from intense competition within the diagnostic healthcare industry. Rival companies with similar capabilities and service offerings pose a challenge to the company's market share.
- Additionally, changes in healthcare policies and regulations, especially related to reimbursements and pricing, can impact the company's profitability and sustainability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.